株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インテリジェント喘息モニタリング装置の世界市場:機会分析と産業予測

Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices, and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

発行 Allied Market Research 商品コード 763996
出版日 ページ情報 英文 175 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
インテリジェント喘息モニタリング装置の世界市場:機会分析と産業予測 Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices, and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
出版日: 2018年12月18日 ページ情報: 英文 175 Pages
概要

当レポートでは、世界のインテリジェント喘息モニタリング装置市場について調査分析し、市場概要、セグメント別の市場分析、地域別分析、競合情勢など、体系的な情報を提供しています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場定義と範囲
  • 主な調査結果
  • 主要企業ポジショニング
  • 市場力学

第4章 インテリジェント喘息モニタリング装置市場:製品別

  • 概要
  • ウェアラブル喘息モニタリング装置
  • スマート吸入器

第5章 インテリジェント喘息モニタリング装置市場:エンドユーザー別

  • 概要
  • 病院
  • 在宅医療
  • クリニック

第6章 インテリジェント喘息モニタリング装置市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第7章 企業プロファイル

  • Adherium
  • AstraZeneca PLC
  • Cohero Health, Inc.
  • GlaxoSmithKline plc
  • Health Care Originals
  • Koninklijke Philips N.V.
  • PROPELLER HEALTH
  • Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
  • Vectura Group plc
  • Volansys Technologies
図表

List of Tables

LIST OF TABLES

  • TABLE 01. INTELLIGENT ASTHMA MONITORING DEVICES MARKET SEGMENTATION
  • TABLE 02. TOP INVESTMENT POCKETS
  • TABLE 03. TOP PLAYER POSITIONING, 2017
  • TABLE 04. IMPACT ANALYSIS
  • TABLE 05. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 06. INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR WEARABLE ASTHMA MONITORING DEVICES, BY REGION, 2017-2025 ($MILLION)
  • TABLE 07. INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR SMART INHALERS, BY TYPE, 20172025 ($MILLION)
  • TABLE 08. GLOBAL SMART INHALERS MARKET, BY TYPE, 20172025 ($MILLION)
  • TABLE 09. GLOBAL INHALERS MARKET, BY TYPE, 20172025 ($MILLION)
  • TABLE 10. SMART INHALERS MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 11. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 12. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 20172025 ($MILLION)
  • TABLE 13. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOME CARE, BY REGION, 20172025 ($MILLION)
  • TABLE 14. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR CLINICS, BY REGION, 20172025 ($MILLION)
  • TABLE 15. INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 16. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 17. U.S. INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 18. U.S. INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 19. CANADA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 20. CANADA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 21. MEXICO INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 22. MEXICO INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 23. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 24. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 25. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 26. GERMANY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 27. GERMANY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 28. FRANCE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 29. FRANCE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 30. UK INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 31. UK INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 32. ITALY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 33. ITALY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 34. REST OF EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 35. REST OF EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 36. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 37. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 38. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 39. JAPAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 40. JAPAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 41. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 42. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 43. INDIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 44. INDIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 45. AUSTRALIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 46. AUSTRALIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING PRODUCT MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 49. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 50. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 51. LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 52. BRAZIL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 53. BRAZIL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 54. SOUTH AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 55. SOUTH AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 56. SAUDI ARABIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 57. SAUDI ARABIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 58. REST OF LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 59. REST OF LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 60. LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 61. LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 62. ADHERIUM: COMPANY SNAPSHOT
  • TABLE 63. VECTURA GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 64. ADHERIUM: PRODUCT PORTFOLIO
  • TABLE 65. ASTRAZENECA: COMPANY SNAPSHOT
  • TABLE 66. ASTRAZENECA: PRODUCT PORTFOLIO
  • TABLE 67. COHERO HEALTH, LLC: COMPANY SNAPSHOT
  • TABLE 68. COHERO HEALTH, LLC: PRODUCT PORTFOLIO
  • TABLE 69. COHERO HEALTH, LLC: PRODUCT PORTFOLIO
  • TABLE 70. GSK: COMPANY SNAPSHOT
  • TABLE 71. GSK: OPERATING SEGMENTS
  • TABLE 72. GSK: PRODUCT PORTFOLIO
  • TABLE 73. GSK: PRODUCT PORTFOLIO
  • TABLE 74. HEALTH CARE ORIGINALS: COMPANY SNAPSHOT
  • TABLE 75. HEALTH CARE ORIGINALS: PRODUCT PORTFOLIO
  • TABLE 76. HEALTH CARE ORIGINALS: PRODUCT PORTFOLIO
  • TABLE 77. KONINKLIJKE PHILIPS N.V, : COMPANY SNAPSHOT
  • TABLE 78. KONINKLIJKE PHILIPS N.V : OPERATING SEGMENTS
  • TABLE 79. KONINKLIJKE PHILIPS N.V. : PRODUCT PORTFOLIO
  • TABLE 80. PROPELLER: COMPANY SNAPSHOT
  • TABLE 81. PROPELLER: COMPANY SNAPSHOT
  • TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: COMPANY SNAPSHOT
  • TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: OPERATING SEGMENTS
  • TABLE 84. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT PORTFOLIO
  • TABLE 85. VECTURA GROUP PLC: COMPANY SNAPSHOT
  • TABLE 86. VECTURA GROUP PLC: OPERATING SEGMENTS
  • TABLE 87. VECTURA GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 88. VECTURA GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 89. VOLANSYS TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 90. VOLANSYS TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 91. VOLANSYS TECHNOLOGIES: PRODUCT PORTFOLIO

List of Figures

LIST OF FIGURES

  • FIGURE 01. COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR WEARABLE ASTHMA MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 02. GLOBAL DRY POWDERED DOSE MARKET FOR INHALERS, 20172025 ($MILLION)
  • FIGURE 03. GLOBAL METERED DOSE INHALER MARKET FOR INHALERS, 20172025 ($MILLION)
  • FIGURE 04. COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR SMART INHALERS, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 05. COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 06. COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR EYE CLINICS, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 07. COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 08. ADHERIUM: NET SALES, 20152017 ($MILLION)
  • FIGURE 09. ADHERIUM: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 10. ASTRAZENECA: NET SALES, 20152017 ($MILLION)
  • FIGURE 11. ASTRAZENECA: REVENUE SHARE BY PRODUCT, 2017 (%)
  • FIGURE 12. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 13. GSK: NET SALES, 20152017 ($MILLION)
  • FIGURE 14. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 15. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 16. KONINKLIJKE PHILIPS N.V: NET SALES, 20152017 ($MILLION)
  • FIGURE 17. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY SEGMENT, 2017 (%)
  • FIGURE 18. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
  • FIGURE 19. TEVA PHARMACEUTICAL INDUSTRIES LTD: NET SALES, 20152017 ($MILLION)
  • FIGURE 20. TEVA PHARMACEUTICAL INDUSTRIES LTD: REVENUE SHARE, BY SEGMENT, 2017 (%)
  • FIGURE 21. TEVA PHARMACEUTICAL INDUSTRIES LTD: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
  • FIGURE 22. VECTURA GROUP PLC: NET SALES, 20152017 ($MILLION)
  • FIGURE 23. VECTURA GROUP PLC: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 24. VECTURA GROUP PLC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
目次
Product Code: LI_185124

Intelligent Asthma Monitoring Devices Market Overview:

The global intelligent asthma monitoring devices market was valued at $20 million in 2017, and is expected to reach $655 million by 2025, registering a CAGR of 54.5% from 2018 to 2025. Asthma monitoring devices are used to monitor the symptoms of asthma on daily basis to avoid and prevent the asthma attack and its severe complications. The intelligent asthma monitoring devices are equipped with secondary app, which helps medical practitioner in analyzing the level of asthma and its symptoms.

Considerable increase in the incidences of asthma is due to rise in allergic reactions toward the pollen, dust, and other allergens; increase in geriatric population; and technological advancements in the treatment of the asthma, which in turn is expected to drive the growth of the global intelligent asthma monitoring devices market.

The global intelligent asthma monitoring devices market is segmented based on product, end user, and region. Based on product, the market is segmented into wearable asthma monitoring devices and smart inhalers. Smart inhalers segment is further bifurcated into inhalers and nebulizers. Inhalers segment is further segmented into dry powdered inhalers and metered dose inhalers. Based on end user, the market is divided into hospital, clinics, and home use. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for Intelligent Asthma Monitoring Devices Market:

The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Intelligent Asthma Monitoring Devices Key Market Segments:

By Product

  • Wearable Asthma Monitoring Devices
  • Smart Inhalers
  • Inhalers
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Nebulizers

By End User

  • Hospitals
  • Clinics
  • Home Use

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • List Of Key Players Profiled in the Report
  • Vectura Group plc
  • Propeller Health
  • Teva Pharmaceutical Industries Ltd.(Gecko Health Innovations)
  • Adherium Limited
  • Cohero Health, Inc.
  • AstraZeneca plc
  • Health Care Originals
  • Philips Healthcare
  • GlaxoSmithKline plc
  • VOLANSYS

List Of Other Players in the Value Chain(These players are not profiled in the report. The same will be included on request.)

  • Quvium
  • Respiri
  • Circassia
  • Redecol
  • Anaxsys

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List of key players profiled in the report:
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
  • 1.5. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. key findings
    • 3.2.1. Top investment pockets
  • 3.3. Top player positioning
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Global Increase in air pollution
      • 3.4.1.2. Increase in population susceptible to indoor air pollutants
      • 3.4.1.3. Increasing prevalence of COPD and asthma globally
      • 3.4.1.4. Expected increase in adherence to smart inhalers
      • 3.4.1.5. Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
      • 3.4.1.6. Rising incidences of asthma cases
    • 3.4.2. Restraints
      • 3.4.2.1. Misusing data and data privacy
      • 3.4.2.2. Resistance towards adoption of smart inhalers
    • 3.4.3. Opportunities
      • 3.4.3.1. Increased focus towards advanced treatment protocols
      • 3.4.3.2. Significant unmet need in respiratory care
      • 3.4.3.3. Opportunities in emerging economies
      • 3.4.3.4. Impact analysis

CHAPTER 4: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Wearable Asthma monitoring devices
    • 4.2.1. Key trends and opportunities
    • 4.2.2. Market size and forecast
    • 4.2.3. Market analysis, by country
  • 4.3. Smart Inhalers
    • 4.3.1. Key trends and opportunities
    • 4.3.2. Market size and forecast, by type
      • 4.3.2.1. Inhalers
      • 4.3.2.2. Market Size and Forecast
      • 4.3.2.3. Key trends and opportunities
      • 4.3.2.3.1. Dry Powdered Inhalers (DPIs)
      • 4.3.2.3.2. Metered Dose Inhalers (MDI's)
      • 4.3.2.1. Nebulizers
    • 4.3.3. Market size and forecast, by region
    • 4.3.4. Market analysis, by country

CHAPTER 5: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Market size and forecast
    • 5.2.2. Market analysis, by country
  • 5.3. Homecare
    • 5.3.1. Market size and forecast
    • 5.3.2. Market analysis, by country
  • 5.4. Clinics
    • 5.4.1. Market size and forecast
    • 5.4.2. Market analysis, by country

CHAPTER 6: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. North America market size & forecast, by country
      • 6.2.2.1. U.S. market size & forecast, by product
      • 6.2.2.2. U.S. market size & forecast, by end user
      • 6.2.2.3. Canada market size & forecast, by product
      • 6.2.2.4. Canada market size & forecast, by end user
      • 6.2.2.5. Mexico market size & forecast, by product
      • 6.2.2.6. Mexico market size & forecast, by end user
    • 6.2.3. North America market size & forecast, by product
    • 6.2.4. North America market size & forecast, by end user
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Europe market size & forecast for intelligent asthma monitoring devices market, by country
      • 6.3.2.1. Germany market size & forecast, by product
      • 6.3.2.2. Germany market size & forecast, by end user
      • 6.3.2.3. France market size & forecast, by product
      • 6.3.2.4. France market size & forecast, by end user
      • 6.3.2.5. UK market size & forecast, by product
      • 6.3.2.6. UK market size & forecast, by end user
      • 6.3.2.7. Italy market size & forecast, by product
      • 6.3.2.8. Italy market size & forecast, by end user
      • 6.3.2.10. Rest of Europe market size & forecast, by product
      • 6.3.2.11. Rest of Europe market size & forecast, by end user
    • 6.3.3. Europe market size & forecast, by product
    • 6.3.4. Europe market size & forecast, by end user
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Asia-Pacific market size & forecast, by country
      • 6.4.2.1. Japan market size & forecast, by product
      • 6.4.2.2. Japan market size & forecast, by end user
      • 6.4.2.3. China market size & forecast, by product
      • 6.4.2.4. China market size & forecast, by end user
      • 6.4.2.5. India market size & forecast, by product
      • 6.4.2.6. India market size & forecast, by end user
      • 6.4.2.7. Australia market size & forecast, by product
      • 6.4.2.8. Australia market size & forecast, by end user
      • 6.4.2.10. Rest of Asia-Pacific market size & forecast, by product
      • 6.4.2.11. Rest of Asia-Pacific market size & forecast, by end user
    • 6.4.3. Asia-Pacific market size & forecast, by product
    • 6.4.4. Asia-Pacific market size & forecast, by end user
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. LAMEA market size & forecast, by country
      • 6.5.2.1. Brazil market size & forecast, by product
      • 6.5.2.2. Brazil market size & forecast, by end user
      • 6.5.2.3. South Africa market size & forecast, by product
      • 6.5.2.4. South Africa market size & forecast, by end user
      • 6.5.2.5. Saudi Arabia market size & forecast, by product
      • 6.5.2.6. Saudi Arabia market size & forecast, by end user
      • 6.5.2.7. Rest of LAMEA market size & forecast, by product
      • 6.5.2.8. Rest of LAMEA market size & forecast, by end user
    • 6.5.3. LAMEA market size & forecast, by product
    • 6.5.4. LAMEA market size & forecast, by end user

CHAPTER 7: COMPANY PROFILES

  • 7.1. Adherium
    • 7.1.1. Company overview
    • 7.1.2. Company snapshot
    • 7.1.3. Product portfolio
    • 7.1.4. Business performance
    • 7.1.5. Key strategic Moves and Development
  • 7.2. AstraZeneca PLC
    • 7.2.1. Company overview
    • 7.2.2. Company snapshot
    • 7.2.3. Product portfolio
    • 7.2.4. Business performance
    • 7.2.5. Key strategic moves and developments
  • 7.3. Cohero Health, Inc.
    • 7.3.1. Company overview
    • 7.3.2. Company snapshot
    • 7.3.3. Business segment
    • 7.3.4. Product portfolio
    • 7.3.5. Key strategic moves and developments
  • 7.4. GlaxoSmithKline plc
    • 7.4.1. Company overview
    • 7.4.2. Company snapshot
    • 7.4.3. Operating business segments
    • 7.4.4. Product portfolio
    • 7.4.5. Business performance
  • 7.5. Health Care Originals
    • 7.5.1. Company overview
    • 7.5.2. Company snapshot
    • 7.5.3. Product portfolio
    • 7.5.4. Key strategic Moves and Development
  • 7.6. Koninklijke Philips N.V.,
    • 7.6.1. Company overview
    • 7.6.2. Company snapshot
    • 7.6.3. Operating business segments
    • 7.6.4. Product portfolio
    • 7.6.5. Business performance
  • 7.7. PROPELLER HEALTH
    • 7.7.1. Company overview
    • 7.7.2. Company snapshot
    • 7.7.3. Operating business segments
    • 7.7.4. Product Portfolio
    • 7.7.5. Key strategic moves and developments
  • 7.8. Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
    • 7.8.1. Company overview
    • 7.8.2. Company snapshot
    • 7.8.3. Operating business segments
    • 7.8.4. Product portfolio
    • 7.8.5. Business performance
  • 7.9. Vectura Group plc
    • 7.9.1. Company overview
    • 7.9.2. Company snapshot
    • 7.9.3. Operating business segments
    • 7.9.4. Product portfolio
    • 7.9.5. Business performance
    • 7.9.6. Key strategic Moves and Development
  • 7.10. Volansys Technologies
    • 7.10.1. Company overview
    • 7.10.2. Company snapshot
    • 7.10.3. Operating business segments
    • 7.10.4. Product portfolio
Back to Top